ProCE Banner Series

Targeting Antimicrobial Resistance in Complex Gram-Negative Infections: Approaches for Improving Early Effective Therapy

Join us for this interactive webinar on targeting antimicrobial resistance in complex gram-negative infections. Learn about strategies to identify multidrug and extensively drug resistant gram-negative organisms, compare available antimicrobial agents, integrate clinical guidelines, individual patient factors, and laboratory data into selection of optimal treatment regimens to minimize time to effective therapy. After the webinar, view the on-demand webcast and download the associated slide set for use in your practice.

  ACPE-P
Credits Available

1.50

Who Should Attend

The target audience is pharmacists, including clinical and health-system, ambulatory care, and community pharmacists, who care for patients with gram-negative infections as well as pharmacy directors, chief pharmacy officers, and other stakeholders in health-system pharmacy.

All Events

Targeting Antimicrobial Resistance in Complex Gram-Negative Infections: Approaches for Improving Early Effective Therapy (February 2, 2023)

Past Events

February

02

2023

12:00 PM - 1:30 PM Eastern Time (ET)

Virtual

Topics

  • Welcome and Opening Remarks
  • Key Concepts for Antimicrobial Resistance in Gram-Negative Organisms
  • New Antibiotics for Multidrug-Resistant and Extensively Drug-Resistant Gram-Negative Pathogens
  • Tools for Effective Early Empiric and Targeted Gram-Negative Therapy
  • Case Discussions, Key Takeaways, and Audience Question and Answer Session

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge and competence of learners about applying the latest practice guidelines and data for selection of antibiotic regimens for patients with complex infections with MDROs and XDROs.

Target Audience
The target audience is pharmacists, including clinical and health-system, ambulatory care, and community pharmacists, who care for patients with gram-negative infections as well as pharmacy directors, chief pharmacy officers, and other stakeholders in health-system pharmacy.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Differentiate clinically relevant multidrug and extensively drug resistant gram-negative organisms (MDROs, XDROs) including epidemiology, mechanisms of antimicrobial resistance, and virulence factors
  • Compare available antimicrobial agents for difficult-to-treat gram-negative pathogens, including data on efficacy, adverse events, pharmacokinetics/ pharmacodynamics, and antimicrobial spectrum coverage
  • Integrate clinical guidelines, individual patient factors, and laboratory data into the selection of optimal treatment regimens for patients with antimicrobial resistant gram-negative infections
  • Develop strategies to minimize time to effective therapy, incorporating rapid diagnostics and antimicrobial stewardship principles

Accreditation

CE Accreditation

Pharmacists

This activity is jointly provided by ProCE, LLC and the Society of Infectious Diseases Pharmacists (SIDP). ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-23-003-L01-P has been assigned to this live application-based activity (initial release date 2/23/2023). This activity is approved for 1.5 contact hours (0.15 CEUs) in states that recognize ACPE providers. This activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation within 30 days of the activity to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.

Disclosure
ProCE, LLC  requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. Faculty disclosures will be provided prior to the start of the CE activity.

Acknowledgement

Provided by ProCE, LLC

In Partnership with the Society of Infectious Diseases Pharmacists.

Supported by an educational grant from bioMérieux.